1,3-二丙基-8-p-硫化苯基黄嘌呤结构式
|
常用名 | 1,3-二丙基-8-p-硫化苯基黄嘌呤 | 英文名 | 1,3-DIPROPYL-8-P-SULFOPHENYLXANTHINE |
|---|---|---|---|---|
| CAS号 | 89073-57-4 | 分子量 | 392.43000 | |
| 密度 | 1.405g/cm3 | 沸点 | N/A | |
| 分子式 | C17H20N4O5S | 熔点 | >300ºC | |
| MSDS | 中文版 美版 | 闪点 | N/A |
| 中文名 | 1,3-二丙基-8-p-硫化苯基黄嘌呤 |
|---|---|
| 英文名 | 4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)benzenesulfonic acid |
| 中文别名 | 1,3-二丙酯-8-P-三苯基黄嘌呤 | 1,3-二丙基-8-对质硫苯基黄嘌呤 |
| 英文别名 | 更多 |
| 密度 | 1.405g/cm3 |
|---|---|
| 熔点 | >300ºC |
| 分子式 | C17H20N4O5S |
| 分子量 | 392.43000 |
| 精确质量 | 392.11500 |
| PSA | 135.43000 |
| LogP | 2.70080 |
| InChIKey | IWALGNIFYOBRKC-UHFFFAOYSA-N |
| SMILES | CCCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)O)cc3)nc2n(CCC)c1=O |
| 折射率 | 1.607 |
| 储存条件 | 密闭,阴凉,干燥处 |
| 稳定性 | 按规定使用和贮存的不会分解,避氧化物 |
| 分子结构 | 1、 摩尔折射率:96.51 2、 摩尔体积(m3/mol):279.1 3、 等张比容(90.2K):779.7 4、 表面张力(dyne/cm):60.8 5、 极化率(10-24cm3):38.26 |
| 计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:2 3.氢键受体数量:6 4.可旋转化学键数量:6 5.互变异构体数量:4 6.拓扑分子极性表面积132 7.重原子数量:27 8.表面电荷:0 9.复杂度:671 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
| 更多 | 1. 性状:白色固体 2. 密度(g/mL25ºC):未确定 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(ºC):>300 5. 沸点(ºC,常压):未确定 6. 沸点(ºC20mmHg):未确定 7. 折射率:未确定 8. 闪点(ºF):未确定 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC):未确定 11. 蒸气压(Pa,):未确定 12. 饱和蒸气压(kPa,60ºC):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(正辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:H2O: 0.43 mg/mL |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 安全声明 (欧洲) | S22-S24/25 |
| 危险品运输编码 | NONH for all modes of transport |
| 海关编码 | 2933990090 |
|
~%
1,3-二丙基-8-p-硫化苯基黄嘌呤 89073-57-4 |
| 文献:Journal of Medicinal Chemistry, , vol. 28, # 4 p. 487 - 492 |
|
~%
1,3-二丙基-8-p-硫化苯基黄嘌呤 89073-57-4 |
| 文献:Journal of Medicinal Chemistry, , vol. 28, # 4 p. 487 - 492 |
|
~%
1,3-二丙基-8-p-硫化苯基黄嘌呤 89073-57-4 |
| 文献:Journal of Medicinal Chemistry, , vol. 28, # 4 p. 487 - 492 |
|
~%
1,3-二丙基-8-p-硫化苯基黄嘌呤 89073-57-4 |
| 文献:Journal of Medicinal Chemistry, , vol. 28, # 4 p. 487 - 492 |
| 1,3-二丙基-8-p-硫化苯基黄嘌呤上游产品 3 | |
|---|---|
| 1,3-二丙基-8-p-硫化苯基黄嘌呤下游产品 1 | |
| 海关编码 | 2933990090 |
|---|---|
| 中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Extracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cells.
Am. J. Physiol. Renal Physiol. 304(1) , F49-55, (2013) In a previous study, we demonstrated that human proximal tubular epithelial cells obtained from a commercial source metabolized extracellular 2',3'-cAMP to 2'-AMP and 3'-AMP and extracellular 2'-AMP a... |
|
|
Expression of the 2',3'-cAMP-adenosine pathway in astrocytes and microglia.
J. Neurochem. 118 , 979-987, (2011) Many organs express the extracellular 3',5'-cAMP-adenosine pathway (conversion of extracellular 3',5'-cAMP to 5'-AMP and 5'-AMP to adenosine). Some organs release 2',3'-cAMP (isomer of 3',5'-cAMP) and... |
|
|
Sustained reduction in myocardial reperfusion injury with an adenosine receptor antagonist: possible role of the neutrophil chemoattractant response.
J. Pharmacol. Exp. Ther. 292(3) , 929-38, (2000) Recent studies have demonstrated that three membrane-permeant A(1) receptor antagonists reduced infarct size in a model of ischemia followed by brief reperfusion. However, it was not determined whethe... |
|
实验名称:Luminescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:mu-type opioid receptor isoform MOR-1 [Homo sapiens]
External Id:OPRM1-OPRD1_AG_LUMI_1536_1X%ACT PRUN
|
|
实验名称:Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay
来源:ChEMBL
靶标:N/A
External Id:CHEMBL1266185
|
|
实验名称:Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
来源:NCGC
External Id:SNCA-p-activity-luciferase
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:Dicer-mediated maturation of pre-microRNA
来源:Center for Chemical Genomics, University of Michigan
靶标:N/A
External Id:TargetID_659_CEMA
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify pos...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_PAM_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:Fluorescence polarization-based biochemical high throughput primary assay to identify...
来源:The Scripps Research Institute Molecular Screening Center
靶标:RecName: Full=Sialate O-acetylesterase; AltName: Full=H-Lse; AltName: Full=Sialic acid-specific 9-O-acetylesterase; Flags: Precursor [Homo sapiens]
External Id:SIAE_INH_FP_1536_1X%INH PRUN
|
| 1,3-Dspx |
| 4-(2,3,6,7-Tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-benzenesulfonic acid |
| Benzenesulfonic acid,4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl) |
| DPSPX |
| PSPX |
| 1,3-Dipropyl-8-(p-sulfophenyl)xanthine |
| 4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)benzenesulfonic acid |
| MFCD00055080 |